Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: a study of the cancer and leukemia group B. - Wikidata - wikimedia - TriplyDB

Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: a study of the cancer and leukemia group B.

Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: a study of the cancer and leukemia group B.

http://www.wikidata.org/entity/Q34128471

about

Erythropoiesis-stimulating agents for myelodysplastic syndromes Hypomethylating agents for patients with myelodysplastic syndrome Erythropoiesis-stimulating agents for myelodysplastic syndromes Hypomethylating agents for patients with myelodysplastic syndrome Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study Safety and efficacy of azacitidine in myelodysplastic syndromes Use of azacitidine for myelodysplastic syndromes: controversial issues and practical recommendations Epigenetic approaches in the treatment of myelodysplastic syndromes: clinical utility of azacitidine An update on the safety and efficacy of decitabine in the treatment of myelodysplastic syndromes A Perspective on the Comparative Antileukemic Activity of 5-Aza-2'-deoxycytidine (Decitabine) and 5-Azacytidine (Vidaza)Safety and efficacy of azacitidine in the treatment of elderly patients with myelodysplastic syndrome Decitabine in the treatment of myelodysplastic syndromes New molecularly targeted therapies for lung cancer A clinical-molecular update on azanucleoside-based therapy for the treatment of hematologic cancers Targeting epigenetic pathways in acute myeloid leukemia and myelodysplastic syndrome: a systematic review of hypomethylating agents trials DNA Methylation and Chromatin Remodeling: The Blueprint of Cancer Epigenetics Molecular and Cellular Mechanisms of Myelodysplastic Syndrome: Implications on Targeted Therapy Defining and Treating Older Adults with Acute Myeloid Leukemia Who Are Ineligible for Intensive Therapies Myelodysplastic syndromes: 2015 Update on diagnosis, risk-stratification and management Alteration of Epigenetic Profile in Human Hepatocellular Carcinoma and Its Clinical Implications High-throughput sequencing for biology and medicine Beyond hypomethylating agents failure in patients with myelodysplastic syndromes The cancer epigenome: its origins, contributions to tumorigenesis, and translational implications New ways to use DNA methyltransferase inhibitors for the treatment of myelodysplastic syndrome Infections in myelodysplastic syndromes Histone lysine-specific methyltransferases and demethylases in carcinogenesis: new targets for cancer therapy and prevention Myelodysplastic syndromes: what do hospitalists need to know?Epigenetics meets radiation biology as a new approach in cancer treatment Clinical Results of Hypomethylating Agents in AML Treatment DNMT3A Mutations in Acute Myeloid Leukemia Recurrent DNMT3A mutations in patients with myelodysplastic syndromes DNMT3A mutations and response to the hypomethylating agent decitabine in acute myeloid leukemia.Epigenetic Therapeutics: A New Weapon in the War Against Cancer Refractory anemia with ring sideroblasts and RARS with thrombocytosis Oral Azacitidine (CC-486) for the Treatment of Myelodysplastic Syndromes and Acute Myeloid Leukemia Decitabine and vorinostat cooperate to sensitize colon carcinoma cells to Fas ligand-induced apoptosis in vitro and tumor suppression in vivo Feasibility of therapy with hypomethylating agents in patients with renal insufficiency A comparison of azacitidine and decitabine activities in acute myeloid leukemia cell lines Equitoxic doses of 5-azacytidine and 5-aza-2'deoxycytidine induce diverse immediate and overlapping heritable changes in the transcriptome Oxidative stress induces monocyte necrosis with enrichment of cell-bound albumin and overexpression of endoplasmic reticulum and mitochondrial chaperones

P2860

Q24186244-64BAEA01-0489-45B6-A397-7CF6EE8D026E Q24186276-9BCC5864-A15A-4CB9-80D7-AE2091C18875 Q24202526-363A17F7-2D7E-4CEA-87E6-789668E6955B Q24236549-DED9684D-310A-441C-B7C7-6186BFC7A12F Q24563021-DA449830-F531-4057-8EF5-CBCE5709CDA3 Q24596561-75F6218B-0F96-41FE-AAA2-428A832B7C17 Q24605618-25A83E33-509B-4D27-A282-E4EB0C2984B3 Q24608659-F87B07A2-F4E2-4223-AEF2-5D69061D600B Q24622700-0FA843F7-5D79-42A8-AA78-046BEDC3B2DE Q24628329-DF0FABA8-C7D1-4250-B7E1-2B9A64F8C792 Q24632949-D6545DBC-DE66-4CE7-B356-A7E572C93C92 Q24641906-156AACD7-1650-45EA-851D-1D2F407C3B0E Q24680988-3CD730BC-08D3-408F-BD78-69FD4443A224 Q26743743-330DB7F3-81F0-4C84-ADB1-D7D8346424E4 Q26745731-729945DC-193D-45F6-8C46-7A51E7B8B849 Q26749421-C36BFEAE-8896-4FB3-91F2-1966151CB840 Q26749870-922A668A-09FD-4273-AA53-038EBB80A7E9 Q26772235-512681EE-177C-49C0-B7C5-F7DC9C328A1A Q26796240-E668B04D-BE59-4541-83D3-29314D364969 Q26797616-1350311F-5657-4303-B2C2-CEBC2A1D4EBB Q26823498-0C645581-74F2-433B-9478-5C69B6FA922E Q26827079-A2733518-97D7-4468-BE7B-C53BA41092A5 Q26828751-5AA362C5-39DF-4561-97FA-28E0D3FDA4A4 Q26829132-9B9FAB64-D46B-461A-8F42-1B683CA2BAC2 Q26859275-9DFFCDD5-F490-46AB-90AF-959558E07D49 Q26994739-B8913B32-E5EC-47F4-8260-57D7B18538E2 Q27011372-42665231-DE68-4BB6-A977-42A0AE122AB8 Q27014984-1D647B4F-68F4-4992-A72F-6B60981B036D Q27022725-0FD76B47-6576-4180-9627-BBF730999AAA Q27559610-123950F0-E00D-41E3-8111-54C64B7D0D35 Q27851629-B1645710-100C-41D0-9191-1376F6917132 Q27851689-9F03879A-E5BC-42E4-81DC-40DBD890D028 Q28072370-44B4CF0E-7F29-4632-9A8A-57A9BDF08208 Q28083238-2879034E-9A9D-40F5-9FA9-0AA3D37E3F95 Q28084813-02986308-7E7C-406B-9CCA-1275C81914C2 Q28263221-E72A4B3F-A634-4050-856E-47D046AC991D Q28283836-9CEEB14B-1DE3-4A87-BA04-E4DBD56BAD2C Q28472733-EA517C5A-BE67-48C7-957C-0FAED32294AA Q28475641-85921250-6392-44C8-81BD-907479536186 Q28488971-5015C772-8F58-43C7-8976-4E8A891DC138

P2860

Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: a study of the cancer and leukemia group B.

http://www.wikidata.org/entity/Q34128471

description

2002 nî lūn-bûn

@nan

2002 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Randomized controlled trial of ...... e cancer and leukemia group B.

@ast

Randomized controlled trial of ...... e cancer and leukemia group B.

@en

Randomized controlled trial of ...... e cancer and leukemia group B.

@nl

type

label

Randomized controlled trial of ...... e cancer and leukemia group B.

@ast

Randomized controlled trial of ...... e cancer and leukemia group B.

@en

Randomized controlled trial of ...... e cancer and leukemia group B.

@nl

prefLabel

Randomized controlled trial of ...... e cancer and leukemia group B.

@ast

Randomized controlled trial of ...... e cancer and leukemia group B.

@en

Randomized controlled trial of ...... e cancer and leukemia group B.

@nl

P1433

Q34128471-B3F7BDB8-7E5A-4659-B385-CDAF538AEF8B

P1476

Q34128471-AF5768EA-0B80-4E97-A013-EBD01B6B3FBC

P2093

Q34128471-19957ECF-17C1-49BA-AE61-3B54F6E45C6E

Q34128471-1B42DE16-555D-4D6B-A330-DF21F1FF260E

Q34128471-22371191-9E37-407F-B3EB-54A09BA98BC3

Q34128471-44A9859C-B06B-4E52-8AEE-748C4B92DC66

Q34128471-4ABC6B21-9DE5-47BD-8BD9-45E5E297B17A

Q34128471-58A059F3-63F8-46FB-BE09-1C8EA8A0EAE4

Q34128471-78A4422E-511D-4030-9FD1-4CA42F26C3FE

Q34128471-7D5DCA3A-639A-414D-A012-0A15FD6906AE

Q34128471-B74C3033-9719-44E7-B813-389924308ACA

Q34128471-CB2629DC-A15F-42AB-A540-FD37A47DB8A8

P304

Q34128471-FF781DF4-96E8-4A48-9925-C4701A8D0F6B

P31

Q34128471-BD2AB968-BA3B-4C3B-8DBE-EBF2CC7F0DC9

P356

Q34128471-BED2B424-4FE8-4888-B965-3A5C4AA37644

P407

Q34128471-16B7B518-0EE3-480F-8DBD-D78FB7C143D2

P433

Q34128471-53A7F082-3D17-456B-8DC1-CC8F0D2E93AB

P478

Q34128471-C7E24F04-F345-4B0A-83AE-873741016814

P50

Q34128471-72FB634C-D319-42A1-97F0-325BC03DF836

Q34128471-FD247616-6CDB-4E44-A321-B4C74D047E30

P577

Q34128471-140E9AF5-ACC8-4575-A9F2-DE0C9F4275EC

P698

Q34128471-6B0D4827-D038-4739-8CAD-6757DD7BC07C

P921

Q34128471-752F9F87-27D5-44C0-B67F-FCC4D2277EE1

Q34128471-986AAB15-41CF-4118-98EE-3D686592027C

P356

JCO.2002.04.117

P1433

Journal of Clinical Oncology

P1476

Randomized controlled trial of ...... e cancer and leukemia group B.

@en

P2093

Alice B Kornblith

http://www.w3.org/2001/XMLSchema#string

Bayard L Powell

http://www.w3.org/2001/XMLSchema#string

Bercedis L Peterson

http://www.w3.org/2001/XMLSchema#string

Carlos M DeCastro

http://www.w3.org/2001/XMLSchema#string

Charles A Schiffer

http://www.w3.org/2001/XMLSchema#string

Douglas Nelson

http://www.w3.org/2001/XMLSchema#string

Erin P Demakos

http://www.w3.org/2001/XMLSchema#string

James F Holland

http://www.w3.org/2001/XMLSchema#string

John Ellerton

http://www.w3.org/2001/XMLSchema#string

Lewis R Silverman

http://www.w3.org/2001/XMLSchema#string

P304

2429-2440

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JCO.2002.04.117

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P50

Richard A. Larson

Jimmie C. Holland

P577

2002-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12011120

http://www.w3.org/2001/XMLSchema#string

P921